Potent inhibition by star fruit of human cytochrome P450 3A (CYP3A) activity

被引:47
|
作者
Hidaka, M [1 ]
Fujita, K [1 ]
Ogikubo, T [1 ]
Yamasaki, K [1 ]
Iwakiri, T [1 ]
Okumura, M [1 ]
Kodama, H [1 ]
Arimori, K [1 ]
机构
[1] Miyazaki Med Coll Hosp, Dept Pharm, Kiyotake, Miyazaki 8891692, Japan
关键词
D O I
10.1124/dmd.32.6.581
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
There has been very limited information on the capacities of tropical fruits to inhibit human cytochrome P450 3A (CYP3A) activity. Thus, the inhibitory effects of tropical fruits on midazolam 1'-hydroxylase activity of CYP3A in human liver microsomes were evaluated. Eight tropical fruits such as common papaw, dragon fruit, kiwi fruit, mango, passion fruit, pomegranate, rambutan, and star fruit were tested. We also examined the inhibition of CYP3A activity by grapefruit ( white) and Valencia orange as controls. The juice of star fruit showed the most potent inhibition of CYP3A. The addition of a star fruit juice (5.0%, v/v) resulted in the almost complete inhibition of midazolam 1'-hydroxylase activity (residual activity of 0.1%). In the case of grapefruit, the residual activity was 14.7%. The inhibition depended on the amount of fruit juice added to the incubation mixture (0.2-6.0%, v/v). The elongation of the preincubation period of a juice from star fruit (1.25 or 2.5%, v/v) with the microsomal fraction did not alter the CYP3A inhibition, suggesting that the star fruit did not contain a mechanism-based inhibitor. Thus, we discovered filtered extracts of star fruit juice to be inhibitors of human CYP3A activity in vitro.
引用
收藏
页码:581 / 583
页数:3
相关论文
共 50 条
  • [41] Unchanged cytochrome P450 3A (CYP3A) expression and metabolism of midazolam, triazolam, and dexamethasone in mdr(-/-) mouse liver microsomes
    Perloff, MD
    von Moltke, LL
    Cotreau, MM
    Greenblatt, DJ
    BIOCHEMICAL PHARMACOLOGY, 1999, 57 (11) : 1227 - 1232
  • [42] Clotrimazole, but not dexamethasone, is a potent in vitro inhibitor of cytochrome P450 isoforms CYP1A and CYP3A in rainbow trout
    Burkina, Viktoriia
    Zlabek, Vladimir
    Zamaiatskaia, Galia
    CHEMOSPHERE, 2013, 92 (09) : 1099 - 1104
  • [43] Localization of cytochrome P450 3A (CYP3A) protein and detection of CYP3A4 and 3A7 mRNA by RT-PCR in human gastrointestinal tract
    Kakiki, M
    Doy, M
    Yokose, T
    Sawa, Y
    Tadano, K
    FASEB JOURNAL, 1997, 11 (09): : A825 - A825
  • [44] Irreversible inhibition of intestinal cytochrome 3A (CYP3A) by clarithromycin.
    Pinto, AG
    Chalasani, N
    Hall, SD
    Ali, A
    Hamman, M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P61 - P61
  • [45] Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: Role of phenolic hydroxyl groups in the resorcinol moiety
    Yamaori, Satoshi
    Ebisawa, Juri
    Okushima, Yoshimi
    Yamamoto, Ikuo
    Watanabe, Kazuhito
    LIFE SCIENCES, 2011, 88 (15-16) : 730 - 736
  • [46] Identification of polymorphisms in the 3′-untranslated region of the human pregnane X receptor (PXR) gene associated with variability in cytochrome P450 3A (CYP3A) metabolism
    Oleson, L.
    von Moltke, L. L.
    Greenblatt, D. J.
    Court, M. H.
    XENOBIOTICA, 2010, 40 (02) : 146 - 162
  • [47] A Comprehensive Investigation of Dog Cytochrome P450 3A (CYP3A) Reveals a Functional Role of Newly Identified CYP3A98 in Small Intestine
    Uno, Yasuhiro
    Jikuya, Shiori
    Noda, Yutaro
    Murayama, Norie
    Yamazaki, Hiroshi
    DRUG METABOLISM AND DISPOSITION, 2023, 51 (01) : 38 - 45
  • [48] Inhibition of cytochrome P450 3A:: Relevant drug interactions in gastroenterology
    Sagir, A
    Schmitt, M
    Dilger, K
    Häussinger, D
    DIGESTION, 2003, 68 (01) : 41 - 48
  • [49] In silico and in vitro inhibition of cytochrome P450 3A by synthetic stilbenoids
    Basheer, Loai
    Schultz, Keren
    Guttman, Yelena
    Kerem, Zohar
    FOOD CHEMISTRY, 2017, 237 : 895 - 903
  • [50] Prediction of cytochrome P450 3A inhibition by verapamil enantiomers and their metabolites
    Wang, YH
    Jones, DR
    Hall, SD
    DRUG METABOLISM AND DISPOSITION, 2004, 32 (02) : 259 - 266